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Running head: Risk factors for Ebola transmission in Guinea 
ABSTRACT 
Understanding risk factors for Ebola transmission is key for effective prediction and design 
of interventions. We used data on 860 cases in 129 chains of transmission from the latter 
half of the 2013-16 Ebola outbreak in Guinea. Using negative binomial regression, we 
determined characteristics associated with the number of secondary cases resulting from 
each infected individual. We found that attending an Ebola Treatment Unit was associated 
with a 38% decrease in secondary cases (Incident rate ratio (IRR) 0.62, 95%CI: 0.38, 0.99) in 
individuals that did not survive. Unsafe burial was associated with a higher number of 
secondary cases (IRR 1.82, 95%CI: 1.10, 3.02). The average number of secondary cases was 
higher for the first generation of a transmission chain (mean = 1.77), compared with 
subsequent generations (mean = 0.70). Children were least likely to transmit (IRR 0.35 
(95%CI: 0.21, 0.57) compared with adults, whereas older adults were associated with higher 
numbers of secondary cases. Men were less likely to transmit than women (IRR 0.71 (95%CI: 
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0.55, 0.93)).  This detailed surveillance dataset provided an invaluable insight into 
transmission routes and risks. Our analysis highlights the key role that age, receiving 
treatment, and safe burial played in the spread of EVD. 
KEYWORDS 
Ebola; Risk factors; Regression analysis; Multiple imputation; Guinea 
 
ABBREVIATIONS 
EVD  Ebola virus disease 
CI  Confidence interval 
IRR  Incidence Rate Ratio 
ETU  Ebola Treatment Unit 
IQR  Interquartile Range 
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Between December 2013 and June 2016, the largest Ebola virus disease (EVD) epidemic to 
date occurred in West Africa, causing more than 28,000 cases mainly in Liberia, Sierra Leone 
and Guinea (1). Of these, 3,804 confirmed cases and 2,536 deaths were in Guinea (1). There 
remains a pressing need to understand the transmission dynamics of this outbreak, so that 
interventions can be designed, and accurate forecasts can be made as outbreaks continue 
to occur (2,3).  
During the 2013-16 epidemic in Guinea, intensive epidemiological investigation was made of 
cases, including assembling those individuals into chains of transmission, which link infected 
individuals to their descendant cases during case investigations (4). In contrast to studies of 
cases, which can give insight only on risk factors for acquisition of EVD (4–6), or genetic 
analysis, which has been used to reconstruct spatial dispersion of the disease in different 
regions (7), transmission chains allow detailed analyses of the risk factors for onward 
transmission (8,9). These data are invaluable for understanding the characteristics of 
individuals likely to have high onward transmission, but have so far been underused in 
analyses of this outbreak.  
Using a large database of epidemiologically-reconstructed transmission chains we 
summarized information on cases reported in the late stages of the 2013-16 outbreak in 
Guinea. We used this information to identify characteristics of cases that were associated 
with increased onward transmission.  
METHODS OR
IG
IN
AL
 U
NE
DI
TE
D 
MA
NU
SC
RI
PT
D
ow
nloaded from
 https://academ
ic.oup.com
/aje/advance-article-abstract/doi/10.1093/aje/kw
z090/5426492 by London School of H
ygiene & Tropical M
edicine user on 05 April 2019
 5 
Data from two databases were linked in this study: the transmission chain dataset (1012 
cases) and the Guinean surveillance database of EVD cases. 152 individuals in the 
transmission chain dataset were participants in the Ebola ça Suffit ring vaccination trial 
(10,11). These cases were removed because of the likely impact of the trial on transmission, 
leaving 860 cases used in this analysis. 
Transmission chain dataset 
Data on cases and the epidemiological links between them were collected by the Ministère 
de la Santé et de l'Hygiène Publique of Guinea (Ministry of Health and Public Hygiene) 
during the epidemic. Field teams conducted interviews with cases (where possible) and their 
contacts, as part of epidemiological investigations. Based on contact with confirmed or 
probable cases, the most likely infector or infectors were assigned to each case. The chains 
of transmission were continually revised and updated during the EVD response in Guinea, 
and when new cases were confirmed those were added to the database and to the chains. 
This could result in changes to the likely infector or joining sub-trees together as new 
information became available. The chains therefore represent the best possible 
epidemiological linkage of cases to each other, made by trained field teams with access to 
cases, contacts, and contextual information. We restricted our analysis to confirmed and 
probable cases infected between September 2014 and November 2015 because 
transmission chains were available during this time period, and resources were available to 
digitize these data.  OR
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Variables were the age, gender, location (prefecture, sub-prefecture and village), survival 
status of the case, whether the burial was safe or unsafe, the epidemiologically-inferred 
source of infection, and the route of transmission (including household, nosocomial, 
neighbor, ETU), national identification number for each individual (Table 1). Geographic 
information, demographic variables and the probable routes of transmission were 
ascertained by the field epidemiology teams (Web Appendix 1). Safe burial means that it 
was safe and dignified burial conducted by a trained burial team. We used dates of: i) onset, 
ii) admission to Ebola treatment unit (ETU), iii) discharge from an ETU, iv) death, and v) 
burial. We deleted 10 implausible epidemiological links (for example, where the end of 
symptoms of the infectee is earlier than the start of symptoms of the named infector). 
When several infectors were reported and plausible for a case, we considered only one link 
in the transmission chain by random selection. We conducted sensitivity analysis on this 
selection.  
Guinea surveillance database 
The Guinean surveillance database is a line list of confirmed cases in Guinea from the 
national surveillance system. Each record contains the same information on each case as the 
transmission chain dataset, except for the transmission link, but completeness of other 
fields (such as dates) is higher. Therefore, we matched the transmission chain dataset to the 
surveillance database using national identification number, or name, location, age, and 
dates of infection. This increased the completeness of the data used in this analysis. 
Matching cases 
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664 cases in the transmission chain dataset (77.2%) matched with a record in the 
surveillance database. 135 (15.7%) of these did not provide extra information on the case. 
We compared the features of the 529 remaining cases in each database to eliminate 
mismatches (Web Appendix 2, Web Figures 1-2) and used the surveillance database to 
supplement features of 380 (44.2%) cases. Among these cases, all reported variables 
matched for 71 individuals, and the surveillance database contributed information for 380 
cases. In cases that were not perfect matched, the mismatches were minor and we assumed 
these differences were due to data entry errors as other variables matched (Web Appendix 
2). For the other cases, we kept the features described in the transmission chain dataset. 
196 of the 860 individuals in the transmission chain dataset could not be matched to cases 
in the Guinean surveillance database (22.8%). Table 1 shows reporting and values of each 
variable in the final dataset. 
Classification by number of transmissions 
We calculated the number of reported secondary cases for each individual, and categorized 
them as: i) high transmitters (more than 3 cases), ii) moderate transmitters (1 to 3 cases), iii) 
no onward transmission, and tested for associations with demographic characteristics (Web 
Appendix 3, Web Figure 3). 
Statistical analysis 
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We used negative binomial regression to estimate the impact of characteristics of the cases 
on the number of secondary cases caused (17). We grouped the age of cases into: 0-14; 15-
34; 35-54; 55-74; 75+ years. Conakry and Prefecture city centers were considered as urban 
areas, whereas other areas (villages, towns) were defined as rural areas. Cases without a 
known infector were defined as the first generation of a chain, and all others as subsequent 
generations of a chain.  
We created a variable that combined the survival status, ETU attendance, and burial status 
of each case, called the “Outcome”. In the data, all reported survivors had been admitted to 
an ETU and all non-survivors that had been admitted to an ETU had a safe burial. Therefore 
we used four unordered levels describing the outcome of each case: i) Survivor who 
attended an ETU, ii) Non-survivor who attended an ETU and was safely buried , iii) Non-
survivor who did not attend an ETU and was safely buried, iv) Non-survivor who did not 
attend an ETU and was unsafely buried (Web Appendix 3, Web Figure 4).  
Imputation of missing data 
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Four of the variables included in the negative binomial regression analysis were 
incompletely reported: gender (1.7% missing), age (11.8% missing), survival status (4.5% 
missing), burial safety status (29.4% missing) and ETU admission status (13.6% missing) 
(Web Appendix 3, Web Figures 5-6). Since some of the variables were incomplete, and we 
aimed to retain the full population in the regression analysis, we used multiple imputation 
for missing values (12–14). In the imputation model, we considered all factors included in 
the regression analysis as explanatory variables (see below), plus four others from the 
database: the number of community, funeral, or nosocomial transmissions caused, and 
month of onset. The imputed variables were age (using predictive mean matching), survival 
status, burial safety status, and ETU admission status (logistic regression). We assumed that 
missing data were missing at random (15) (Web Appendix 4, Web Table 1, Web Figures 7-8). 
Forty datasets were generated using the MICE package in R version 3.5.0 (16). We used 
pooled coefficient estimates drawn from 40 imputed datasets (Web Appendix 4, Web Table 
2, Web Figure 9), and performed sensitivity analysis on the multiple imputation (Web 
Appendix 5, Web Tables 3-4). 
RESULTS 
Chains of transmission 
The proportion of the total cases represented in this dataset increases through time (Figure 
1). There were 818 cases in 87 chains of transmission of 2 to 11 generations (Figure 1) and 
42 individuals not linked to any infector or to subsequent cases. These first generation cases 
occurred throughout the study period (Web Figure 2). The largest chain of transmission 
included 78 cases, starting on 1st January 2015 and ending on 25th April 2015.  
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The mean serial interval (time between the date of onset of the infected case and onset in 
their infector) was 12.3 days (Figure 2A), calculated from 308 serial intervals. The serial 
interval did not vary through time (Figure 2A), by route of transmission, age, or by 
generation of the chain (Web Appendix 6, Web Figure 10). 
Reproduction number 
The unadjusted average number of secondary cases per individual was 0.89. Most cases did 
not result in subsequent transmission. 299 (34.8%) cases resulted in at least some 
transmission, and 62 (7.2%) individuals were deemed high transmitters and were 
responsible for 53.5% of the transmission events observed. The maximum number of 
observed secondary cases was 22. We fitted a negative binomial distribution to the number 
of secondary cases and found high dispersion (mean = 0.89, dispersion parameter = 0.31 
(95% CI: 0.25, 0.37), Index of dispersion = 3.87 (95% CI: 3.41, 4.56)). We stratified first and 
subsequent generations and observed a higher reproduction number among first generation 
individuals (mean = 1.77) than among the subsequent generations (mean = 0.70) (Figure 3, 
Web Appendix 6, Web Figure 11).  
Univariable description of transmitters 
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Older cases were more likely to be high transmitters, whereas children or young adults were 
less likely to transmit: 49.4% of the cases who did not cause any transmission are younger 
than 30, whereas only 11.3% of high transmitters falls into this age category (Figure 2B). We 
did not observe any change in the route of transmission between moderate and high 
transmitters (Figure 2C). The major route of transmission was through the household (57.9% 
of all cases and 75.9% of transmission events). We did not observe any difference between 
case characteristics (such as gender and location) and classification of high, moderate, or no 
transmission (Web Appendix 3, Web Figure 3).  
Determinants of transmission  
We found significant associations of gender, outcome (four unordered levels), age category 
and being the first generation of a chain, with the number of secondary cases generated 
(Table 2). In our multivariable negative binomial regression model, the estimated intercept 
was 0.69 (95% CI: 0.38, 1.28) and was defined as the mean number of secondary cases for 
women, aged 35-54, who did not survive, did not go to an ETU, and had a safe burial, in 
urban area and were not the first generation of a chain (Table 2). 
Individuals younger than 35 caused significantly fewer secondary cases, and the first 
generation of chains caused significantly more secondary case than subsequent generations 
(incidence rate ratio (IRR) = 1.76 (95%CI: 1.27, 2.44)). Men caused significantly fewer 
secondary cases than women (IRR= 0.71 (95%CI: 0.55, 0.93)), which was not observed in the 
univariable analysis.  OR
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By comparing the coefficients for non-survivors who did and did not attend an ETU, but had 
safe burials, we determined that there was a significantly lower number of secondary cases 
in those who attended an ETU (IRR = 0.62 (95%CI: 0.38, 0.99)). We found that unsafe burial 
was associated with a large increase in transmission (IRR = 1.82 (95% CI: 1.10, 3.02)). We 
compared individuals who survived with non-survivors in those who attended an ETU and 
had a safe burial, and found that survival was associated with significantly fewer secondary 
cases than non-survival (IRR = 0.51 (95%CI: 0.31, 0.82)) (Web Table 3). 
There was no significant association between urban or rural location and number of 
subsequent cases.  
DISCUSSION 
Using the largest set of epidemiologically-linked transmission trees available for EVD, we 
identified key patient characteristics associated with increased onward transmission and 
estimated their association with the number of secondary cases each case generated. By 
doing this we have been able to quantify the association between attending an ETU and safe 
burials on onward transmission, in the late stage of the epidemic in Guinea.  
Attending an ETU was associated with a large decrease in the number of transmission 
events, and unsafe burial was associated with an almost twofold increase in number of 
transmissions. Our estimates emphasize the importance of ETU attendance and safe burials 
as control measures for Ebola, and are similar to values found in other studies (8,18–22). 
These data are drawn from the late stage of the epidemic, and the same risk factors for 
transmission extend even late in the epidemic, when awareness of EVD transmission routes 
may have been higher. 
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In agreement with previous studies of EVD transmission, we found a highly skewed 
distribution of secondary cases (18,19,23–25). Indeed, the majority of cases did not transmit 
EVD at all, and only a small number had high numbers of transmission events (26). 
Importantly, we were able to determine the case-characteristics associated with the 
number of transmissions. This information could be used in real-time prediction, by 
incorporating information on the case mix of incident cases.  
Our analysis is of disjoint transmission chains, which are observations of a fully-connected 
transmission tree. This complete tree contains the entire outbreak, with each case linked 
together. Our findings relating to the first generation of each chain are therefore a measure 
of the impact of a case not having a traced link to a prior case, and not the absence of a true 
link to a prior case. 
We found that the first generation of each chain was associated with a higher number of 
secondary cases than those identified later in the chain. The first generation of each chain is 
necessarily an individual who could not be epidemiologically-linked to any prior chains by 
the field epidemiology teams. First generation cases may have spent longer in the 
community (and therefore had a longer transmission window) because they either were not 
traced by contact-tracing and therefore did not know they were at risk (27); or they evaded 
contact-tracing (28). Alternatively, or additionally, there may be a bias toward detection of 
large transmission events in our data, whereby untraced contacts are more likely to be 
detected if they give rise to a larger cluster of cases, i.e., ascertainment bias.  OR
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We found that children and young adults had lower onward transmission, whereas older 
adults were more likely to result in large numbers of secondary cases. Several studies have 
determined that children were at lower risk of infection in previous outbreaks (6,29), and 
during the west African epidemic (4,5,30), and behavioral differences in caring roles are 
suggested as the reason (29–31). Our study adds to evidence (32,33) that children were also 
associated with lower risk of onward transmission, although not all analyses find this 
pattern (34). 
Three quarters of reported transmissions were in the household, making it the most 
frequent transmission route. Studies from the early stages of the epidemic found a higher 
contribution from funeral and nosocomial transmission routes (8) than observed here. Our 
findings could be the result of public health interventions to increase safe and dignified 
burials, protect health care workers, and raise awareness of transmission risks (22,35). 
There were several interventions occurring at the time of the study (11,18). We accounted 
for the largest of these – the Ebola ça Suffit ring vaccination trial – by removing participants 
of the trial. Other interventions could have affected transmission, although we did not 
detect an association between time and the number of secondary cases in the model. In 
addition, the study period is in the latter part of the epidemic, and there may be differences 
in inferred transmission risk in other time periods of the epidemic. 
Although we did not find evidence for differences between cases in the transmission chains 
dataset and those not, it is possible that there are different characteristics in the number of 
secondary cases generated.   
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This study is limited to observed cases, and therefore the number of transmission events 
could be lower than the true value. Of note, there were no survivors who did not attend an 
ETU in our data. It is likely that these survivors remained undetected, and therefore we 
could not include transmission risk from these individuals in our analysis. Not attending an 
ETU could be associated with other transmission risks, or with community resistance to 
interventions (36).  
Multiple imputation provides unbiased estimates under the assumption that missing data 
were missing at random: given all the information available, the missing values were similar 
in distribution to the observed values. If, for example, all individuals with an unknown burial 
status in fact had an unsafe burial, then this assumption might be violated, potentially 
leading to bias in the estimated regression coefficients. 
Some of the links inferred by on-the-ground epidemiologists may be incorrect, which could 
affect our estimates of determinants of onward transmission. However, in contrast to other 
studies which retrospectively linked cases into transmission chains (32,37), the chains used 
in our study were generated in real time. Genetic data linking cases together could be used 
to test if there are incorrect links (38), but these data were not available for this study.  
By the end of the epidemic, the chains of transmission represent the best possible record of 
epidemiological investigations of EVD cases in Guinea. During periods of high numbers of 
cases, the epidemiological teams may have been more stretched and therefore surveillance 
effort per case could have been lowered. It is possible that proposed infectors have been 
mis-specified during this time period, which could affect the findings, but, based on the 
characteristics of cases, we think it is unlikely that this would be a systematic error. 
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During the EVD outbreak in Guinea, detailed investigations were conducted around each 
case reported to surveillance, to inform the public health response. This enormous 
undertaking resulted in large quantities of data that provide an invaluable insight into the 
routes and risk of transmission. Recent outbreaks in the Democratic Republic of the Congo 
indicate the vital importance of epidemiologically-informed control measures in the control 
of Ebola (39,40). Analyses of these data reveal the key role that older individuals and those 
that did not seek treatment played in the spread of EVD. 
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FIGURE LEGENDS 
Figure 1. Characteristics of the chains data. A) Time series of the daily incidence in Guinea.  
Light grey is total incidence, and dark grey area shows cases included in this analysis. B) 
Distribution of the number of generations per chain. C) Example of a chain with 9 
generations. Squares mark women, and circles mark men. Lighter shade is under 35 years of 
age, and darker shade is over 35 years of age. 
 
Figure 2. Characteristics of transmission. A) Serial interval through time, overall mean = 12.3 
days. Number of cases in each group: 61, 163, 61, 23 respectively. B) Distribution of the 
transmitter status of the cases depending on the age of the cases. C) Distribution of the 
transmitter status depending on the route of transmission. 
 
Figure 3. Distribution of secondary cases. A) Distribution of the number of secondary cases 
per case, and fit to a negative binomial distribution (blue curves). B) Fits of the first or the 
subsequent generations only (total: Mean = 0.89, sd = 0.31 (95%CI: 0.25, 0.37); 1st gen: 
Mean =1.77, sd = 0.88 (95%CI: 0.53, 1.23), subsequent generation: Mean = 0.70, sd=0.25 
(95%CI: 0.19, 0.30)). 
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Table 1:  
Pre-imputation characteristics of the dataset.  
 
Variable Number %  Transmission status (%) 
   None Moderate High 
Age      
  Children (0-14 years old) 137 15.9  88.3 10.2 1.4 
  Adults (15-99 years old) 621 72.3  64.1 27.3 8.7 
  Unknown 102 11.8  41.2 51.9 6.9 
Gender       
  Male 391 45.5  69.6 24.3 6.2 
  Female 454 52.8  62.3 29.3 8.3 
  Unknown 15 1.7  40.0 60.0 0 
EVD status      
  Confirmed 661 76.9  72.3 23.4 4.2 
  Probable 199 23.1  41.7 41.2 17.1 
Number of reported infectors      
  First generation of a chain 133 15.4  31.6 55.6 12.8 
  1 infector 690 80.2  71.0 22.8 6.2 
  2 infectors 16 1.9  68.8 25.0 6.2 
  3 infectors 21 2.5  85.7 9.5 4.8 
Route of infectiona      
  Household transmission 217 75.9     
  Nosocomial transmission 30 10.5     
  Funeral transmission  36 12.6     
  Other transmission  74 26.2     
Outcome      
  Survivor, ETU+ 235 27.3  85.5 13.2 1.3 
  Non-survivor, ETU+ 232 27.0  71.6 24.6 3.9 
  Non-survivor, ETU-, safe burial  63 7.3  57.1 38.1 4.8 
  Non-survivor, ETU-, unsafe burial  70 8.1  35.7 40.0 24.3 
  Unknown 260 30.2  51.2 37.3 11.5 
Location      
  Rural area 458 53.3  60.0 31.9 8.1 
  Urban area 402 46.7  71.1 22.6 6.2 
 
ETU: Ebola treatment unit. 
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aAs more than 1 route was specified for some cases, we did not compute the transmission 
status for this variable, 286 cases caused transmission. “Survivor, ETU+”: survivor who 
attended an ETU; “Non-survivor, ETU+”: Non-survivor who attended an ETU and was safely 
buried; “Non-survivor, ETU-, safe”: Non-survivor who did not attend an ETU and was safely 
buried; “Non-survivor, ETU-, unsafe”: Non-survivor who did not attend an ETU and was 
unsafely buried. 
 
OR
IG
IN
AL
 U
NE
DI
TE
D 
MA
NU
SC
RI
PT
D
ow
nloaded from
 https://academ
ic.oup.com
/aje/advance-article-abstract/doi/10.1093/aje/kw
z090/5426492 by London School of H
ygiene & Tropical M
edicine user on 05 April 2019
 24 
Table 2: 
Results of regression analysis.  
 
Variable Secondary 
cases 
IRR 95% CI P-value 
Intercept 0.69  0.38, 1.28 0.239 
Gender     
 Female  1 Referent  
 Male  0.71 0.55, 0.93 0.012 
Outcome     
 Alive, ETU+  0.31 0.19, 0.51 P<10-3 
 Dead, ETU+, safe burial  0.62 0.38, 0.99 0.046 
 Dead, ETU-, safe burial  1 Referent  
 Dead, ETU-, unsafe burial  1.82 1.10, 3.02 0.018 
Location     
 Urban  1 Referent  
 Rural  1.18 0.90, 1.54 0.224 
Age (years)     
 0-14   0.35 0.21, 0.57 P<10-3 
 15-34   0.68 0.49, 0.93 0.015 
 35-54   1 Referent  
 55-74   0.94 0.63, 1.40 0.757 
 75-99   1.47 0.55, 3.91 0.438 
Generation number     
 First generation   1.76 1.27, 2.44 0.001 
 Subsequent generations   1 Referent  
 
IRR:  incident rate ratio. 
CI: Confidence interval. 
ETU: Ebola treatment unit. 
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